Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (451-460 of 753) with videos related to

Pageof 76
Sort By:
Breast Cancer Research and Treatment|June 1, 2000
Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatmentM E Sabbioni, H P Siegrist, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study GroupJ Bernhard, C Hürny, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)D Crivellari, K N Price, M Hagen, et al.
Cancer|February 25, 2003
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?Helen Trihia, Susan Murray, Karen Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancerS Gelber, A S Coates, A Goldhirsch, et al.
Cancer Treatment Reviews|May 1, 2012
Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trialsJanaina Brollo, Giuseppe Curigliano, Davide Disalvatore, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
Pageof 76

Showing results (451-460 of 753) with videos related to

Sort By:
Pageof 76
Breast Cancer Research and Treatment|June 1, 2000
Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatmentM E Sabbioni, H P Siegrist, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study GroupJ Bernhard, C Hürny, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)D Crivellari, K N Price, M Hagen, et al.
Cancer|February 25, 2003
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?Helen Trihia, Susan Murray, Karen Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancerS Gelber, A S Coates, A Goldhirsch, et al.
Cancer Treatment Reviews|May 1, 2012
Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trialsJanaina Brollo, Giuseppe Curigliano, Davide Disalvatore, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
Pageof 76